Hemophilia
📧 Sign up to get email alerts when something new happens for Hemophilia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-05-04Clinical Trial Update: Study To Compare On-Demand Treatment To A Prophylaxis Regimen Of BeneFIX In Subjects With Moderately Severe to Severe Hemophilia B [Phase 3]
Phase 3 trial comparing on-demand BeneFIX versus a prophylaxis regimen in subjects with moderately severe to severe Hemophilia B; results we…
-
CLINICAL_TRIALS research · 2015-04-30Clinical Trial Update: Transcultural Multidisciplinary Evaluation of Patients With Hemophili
This clinical trial update from Universidad Católica San Antonio de Murcia describes a transcultural multidisciplinary evaluation of patient…
-
CLINICAL_TRIALS trial_result · 2015-04-20Clinical Trial Update: Non-interventional Observation of Practical Implementation, Efficacy and Safety of Continuous Infusion With KOGENATE Bayer in Surgery
This completed non-interventional study evaluates practical use, efficacy and safety of continuous infusion with KOGENATE Bayer in surgical …
-
CLINICAL_TRIALS trial_result · 2015-04-06Clinical Trial Update: Viral Kinetics in HCV Clearance in Subjects With Hemophilia [Phase 1]
Phase 1 clinical trial evaluating viral kinetics of hepatitis C virus clearance in people with hemophilia; results were posted in 2015.
-
CLINICAL_TRIALS research · 2015-03-20Clinical Trial Update: Quality of Life Study of Helixate NexGen
A quality-of-life study of Helixate NexGen for Hemophilia A has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2015-03-19Clinical Trial Update: The Effect of Functional Activities and Balance Ability With Taping in Subjects of Hemophilia [NA]
Clinical trial update evaluating the effect of taping on functional activities and balance in individuals with hemophilia. The current statu…
-
CLINICAL_TRIALS trial_result · 2015-02-13Clinical Trial Update: Comparison of Prophylaxis and On-demand Treatment in Children With Moderate to Severe Hemophilia A [NA]
This clinical trial update notes a completed study comparing prophylaxis versus on-demand treatment in children with moderate to severe Hemo…
-
FDA approval · 2015-01-23FDA Approved: DESMOPRESSIN ACETATE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for Desmopressin Acetate from Apotex Corp. under an ANDA.
-
CLINICAL_TRIALS trial_result · 2015-01-19Clinical Trial Update: Effekt-2 - Efficacy and Safety of Long-term Treatment With KOGENATE® FS in Latin America
The document reports efficacy and safety data from long-term use of KOGENATE FS (recombinant factor VIII) for hemophilia A in Latin America.
-
FDA approval · 2015-01-14FDA Approved: DESMOPRESSIN ACETATE — Supplemental Application (Bauch & Lomb Incorporated)
FDA approved a supplemental application for desmopressin acetate from Bauch & Lomb Incorporated under an ANDA.
-
CLINICAL_TRIALS trial_result · 2015-01-05Clinical Trial Update: Prophylaxis Versus on Demand Treatment for Children With Hemophilia A [Phase 4]
Phase 4 trial comparing prophylaxis versus on-demand treatment in children with Hemophilia A has completed and posted results.
-
CLINICAL_TRIALS withdrawal · 2014-12-31Clinical Trial Update: Non Neutralizing Antibodies: Prevalence and Characterization
This clinical trial update reports the withdrawal of a study evaluating non-neutralizing antibodies in Hemophilia A.
-
CLINICAL_TRIALS trial_result · 2014-12-25Clinical Trial Update: Haemophilia Patients With Inhibitors Being Treated for Acute Joint Bleeds [Phase 2]
Phase 2 clinical trial update evaluating treatment of acute joint bleeds in patients with hemophilia A or B who have inhibitors; results hav…
-
CLINICAL_TRIALS research · 2014-12-24Clinical Trial Update: Ex Vivo Laboratory Assays Application for Therapy Tailoring in Patients With Severe Bleeding Disorders
A clinical trial update exploring ex vivo laboratory assays to tailor therapy for patients with severe bleeding disorders.
-
CLINICAL_TRIALS trial_result · 2014-12-18Clinical Trial Update: Assessment of the Risk of Inhibitor Formation in Previously Treated Patients With Severe Hemophilia A [Phase 4]
Phase 4 trial update from Bayer evaluating the risk of inhibitor formation in previously treated patients with severe Hemophilia A; the stud…
-
CLINICAL_TRIALS trial_result · 2014-12-17Clinical Trial Update: Study of Modified Recombinant Factor VIII (OBI-1) in Subjects With Congenital Hemophilia A [Phase 3]
Phase 3 trial update for modified recombinant Factor VIII (OBI-1) in congenital Hemophilia A; study terminated with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-12-12Clinical Trial Update: Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Recombinant Coagulation Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously Treated Pediatric Subjects With Hemophilia A [Phase 3]
Phase 3 trial assessing safety, efficacy, and pharmacokinetics of recombinant FVIII Fc fusion protein in previously treated pediatric subjec…
-
CLINICAL_TRIALS trial_result · 2014-12-11Clinical Trial Update: Subclinical Joint Bleeding in Irish Adults With Severe Haemophilia A on Personalised Prophylaxis Regimens [Phase 4]
Phase 4 clinical trial update investigating subclinical joint bleeding in Irish adults with severe Hemophilia A on personalized prophylaxis …
-
CLINICAL_TRIALS trial_result · 2014-11-18Clinical Trial Update: Pharmacokinetics and Safety of a Single Intravenous Infusion of BAY 79-4980 [Phase 1]
This Phase 1 trial evaluated the pharmacokinetics and safety of a single intravenous infusion of BAY 79-4980 in Hemophilia A and has complet…
-
CLINICAL_TRIALS research · 2014-11-04Clinical Trial Update: Evaluate Efficacy and Safety of ADVATE in the Standard Prophylaxis Treatment of Severe or Moderately Severe Hemophilia A [NA]
This clinical trial update investigates the efficacy and safety of Advate (recombinant factor VIII) for standard prophylaxis in severe or mo…
-
CLINICAL_TRIALS trial_result · 2014-11-03Clinical Trial Update: Evaluation of the Reasons and Consequences of Bleeding in Late Teens and Early Adulthood Patients With Severe Hemophilia A
This completed Bayer-sponsored clinical trial evaluates the reasons for and consequences of bleeding in late teens and early adulthood patie…
-
CLINICAL_TRIALS trial_result · 2014-10-31Clinical Trial Update: Efficacy and Safety of ADVATE Standard Prophylaxis to Hemophilia A [NA]
A clinical trial update evaluating the efficacy and safety of ADVATE Standard Prophylaxis in individuals with Hemophilia A, with status curr…
-
CLINICAL_TRIALS trial_result · 2014-10-13Clinical Trial Update: A Study to Compare the Pharmacokinetics and Safety of Replenine®-VF, Replenine® or Other Factor IX in Haemophilia B [Phase 3]
A Phase 3 study comparing the pharmacokinetics and safety of Replenine®-VF, Replenine®, and other Factor IX products in Hemophilia B has com…
-
CLINICAL_TRIALS trial_result · 2014-10-09Clinical Trial Update: Early Prophylaxis Immunologic Challenge (EPIC) Study [Phase 3]
Phase 3 EPIC study in Hemophilia A was terminated; results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-09-17Clinical Trial Update: Post Marketing Observational Study of Reformulated BeneFIX
Post-marketing observational study of reformulated BeneFIX (recombinant coagulation factor IX) for Hemophilia B has completed and results we…